Mitapivat metabolically reprograms human ?-thalassemic erythroblasts, increasing their responsiveness to oxidation.
Siciliano A, D'Alessandro A, Matte A, Bisello G, Bertoldi M, Dzieciatkowska M, Argabright A, Pozzetto RH, Riccardi V, Mattarei A, Ongaro A, Ceolan J, Russo R, Rivadeneyra L, Wind-Rotolo M, Iolascon A, Brugnara C, De Franceschi L. Mitapivat metabolically reprograms human ?-thalassemic erythroblasts, increasing their responsiveness to oxidation. Blood Adv. 2025 Jun 10; 9(11):2818-2830.